METHODS
The Wisconsin Diagnostic Breast Cancer dataset which consisted of 569 cases of benign and malignant
tumors was analyzed retrospectively. The framework proposed combines the deep learning of latent representations
with stacked classification, ensemble-based feature selection, and stacked classification. Performance
evaluation was performed based on sensitivity, specificity, accuracy, F1-score, and area under the
curve (AUC) performed using stratified 10-fold cross-validation. The statistical stability across folds and
the comparison with baseline models were determined with the help of non-parametric tests (p<0.05).
RESULTS
The model had good diagnostic performance with an accuracy of between 91.2-100 (Mean 96), Sensitivity
of 76.2-100, good specificity value, and AUC 0.973-1.000. Variability in performance between
folds was low, and statistically significant enhancement as compared to baseline classifiers were present.
CONCLUSION
The hybrid deep-ensemble model is highly diagnostic, has robust discriminative ability, and ultimately
remains stable, which demonstrates the methodological robustness and diagnostic reliability of the proposed
framework as a proof-of-concept decision-support model for early breast cancer detection, with
potential translational relevance subject to further external clinical validation.
Keywords: Breast cancer detection; clinical decision support; diagnostic reliability; hybrid deep?ensemble learning
Problem Statement, Research Gap and Motivation
The early identification of breast cancer is a vital factor
to achieve better patient results; nevertheless, the
current computational diagnostic strategies tend to
focus on the independent increase of accuracy at the
cost of clinical reliability, stability, and control of false
positives. Most papers are either based on handcrafted
functionality, deep learning models that are computationally
intensive or, are based on single-stage classifiers,
thereby restricting interpretability, generalization
and real-world implementation in routine clinical environments.
Furthermore, there has been less focus on outcome stability and statistical strength across validation
folds diminishing translational confidence. These
gaps have inspired this study to create computationally
efficient, clinically reliable, and interpretable diagnostic
decision-support structure, which is driven by deep latent
representations and by optimizing robustness and
reducing false-positives, and can be readily deployed in
resource-constrained clinical settings.
Novelty and Contributions of the Study
This paper introduces a single-user-friendly hybrid
deep-ensemble decision-support system (HDEL-BC)
to identify breast cancer early in its progression with
the focus on diagnostic accuracy, stability, and clinical
relevance and not individual accuracy improvement. In
the proposed method, the latent features obtained by the
autoencoders are combined with clinically interpretable
standardized diagnostic variables to create a hybrid feature
space that balances predictive accuracy with interpretability.
The framework maintains practical interpretability
at the decision-support level by integrating deep
latent representations with clinically interpretable diagnostic features. To enhance the stability of features and
minimize redundancy, the three-ensemble feature selection
strategy (LASSO, Random Forest, and XGBoost) is
used, and the heterogeneous stacked ensemble classifier
is applied to allow consensus decision making. The
framework has been shown to have a very high specificity
in stratified cross-validation, low false-positive rates,
and outstanding discriminative performance, and its statistical
analysis has shown significant distance superiority
to distance-based classifiers and similar performance
to other strong baseline models. In general, the work
provides a computational efficient and clinically reliable
diagnostic framework that can be employed to screen
breast cancer at the early stage and applied into the clinical
environment with limited resources available.
Study Population and Dataset
These characteristics reflect clinically significant
morphological attributes, such as size of tumor, texture,
perimeter, area, concavity, symmetry, and fractal
attributes. These qualities are habitually put into consideration
when diagnostic assessment is carried out
and offer a proper baseline when automated diagnostic
decision-support systems are assessed.
Data Preprocessing and Bias Mitigation
where ×i denotes the original feature value, and µ
and ó represent the mean and standard deviation computed
from the training data, respectively. The Synthetic
Minority Over-Sampling Technique (SMOTEENN)
was used to deal with the question of class imbalance
between benign and malignant cases. Notably, crossvalidation
was done via standardization and resampling
of the respective train data only in the training data of
every fold of the cross-validation process without data
leakage or optimistic bias. Tests folds were completely
independent during the model development. Although
SMOTEENN introduces synthetic minority samples
during training, its use in this study is restricted exclusively
to the training folds within each cross-validation
iteration, thereby preventing information leakage into
the test data. The objective of resampling is not to model
biological variability directly, but to reduce classifier
bias arising from class imbalance and to stabilize decision
boundaries during learning. Since all performance
metrics are computed on original, non-synthetic samples,
the reported diagnostic outcomes reflect real-case
behavior rather than synthetic artifacts.
Hybrid Deep-Ensemble Diagnostic Framework
Deep Latent Representation Learning: A small autoencoder
neural network was used to train nonlinear
latent features on standardized diagnostic features. It
was based on an encoder-decoder architecture that had
an 8-dimensional bottleneck layer, which allowed the
feature of high dimension in the input to be compressed
into a low-dimensional latent space. The autoencoder
was optimized using mean squared reconstruction error
so that latent features can be extracted that reproduce
a greater number of diagnostic relationships.
Hybrid Feature Construction: The extracted latent
features were also combined with the original standardized
diagnostic features to form a hybrid feature representation
to provide a trade-off between the predictive
performance and the clinical interpretability. Such a strategy does not only retain explicit morphological
data, but also adds nonlinear diagnostic patterns to the
feature space. While the autoencoder-derived latent
features are not individually interpretable, their integration
with original diagnostic variables ensures that
clinically meaningful features continue to contribute to
the final decision-making process.
Ensemble-Based Feature Selection: Since the hybrid
feature set was increased, tri-ensemble feature selection
strategy was utilized in determining stable and
diagnostically telling features. The importance of feature
was estimated independently as:
1. Regularized L1-regularized logistic regression,
2. Random Forest, importance, based on impurity,
And
3. Gradient boosting (XGBoost) gain measures.
The results of these methods were normalized and
the results were combined to produce a consensus
ranking and the features that were ranked highly were
then chosen to be used in further classification. This is
an ensemble method that minimizes the bias of each
model and enhances stability of features.
Stacked Classification Strategy: The prediction of
final diagnosis was done with the help of a stacked
ensemble classifier, which consisted of heterogeneous
base learners such as gradient boosting, random forest,
support vectors machine, and multilayer perceptron
models. A logistic regression meta-learner was used to
combine the probabilistic outputs of the base classifiers
so as to estimate the final probability of malignancy:
where base classifier,
Model Validation Strategy
Outcome Measures
Through means of AUC, a threshold-independent
measure of discriminative performance was conducted.
Statistical Analysis
The dataset used in the study was the Wisconsin Diagnostic
Breast Cancer (WDBC) dataset that included
569 cases of diagnosis classified as either benign or malignant
according to the histopathological results. Both
cases are defined by 30 quantitative findings of diagnosis
on the basis of digitized images of the fine-needle
aspirate (FNA) of the breast masses.[
In order to assure numerical stability and comparability
of all features, all diagnostic variables were z-score
standardized, which is defined as:
The suggested diagnostic framework in Figure 
represents the probability predicted by the
denotes the learned weight, and
ó(.) is the sigmoid activation function.
At one time, stratified 10-fold cross-validation was
used to assess model performance, making sure that the
distribution of classes remains the same in every fold.
Training and independent testing one-fold was applied
in every iteration. The whole process of pre-processing,
feature learning, feature selection, and model training
was performed only in the training folds giving an impartial
approximation of the diagnostic performance.
The diagnostic performance was evaluated by clinically
relevant outcome measures, which were sensitivity,
specificity, accuracy, F1-score, and the area under the receiver operating characteristic curve
(AUC). These measures were stipulated as:
The results of the performance measures were summarized
by cross-validation in terms of the means and variability
estimates. 95% confidence intervals were calculated
where possible. Non-parametric statistical testing was
used to compare the proposed framework and baseline
classifiers and statistical significance was set at two-sided
p-value value smaller than 0.05. The implementation of
all analyses was done based on standard Python-based
scientific computing libraries. The materials and methods
were formulated to allow an objective assessment,
statistical soundness, and clinical significance, therefore,
choosing the applicability of the proposed decision-support
framework to translational applications.
Cross-Validated Diagnostic Performance
The proposed hybrid deep -ensemble learning (HDELBC)
model was tested based on 10-fold cross-validation
with stratification to provide robust and unbiased
estimations of the model performances. Table
Within the validation folds, accuracy varied between 91.2% and 100% with most of the folds having a high value of above 96, which is an indication of consistent generalization. The sensitivity had a range of 76.2% to 100% which indicated conservative behavior in some folds whereas the specificity was always high and in some cases it was 100%. The curve below ROC (AUC) was between 0.973 and 1.000 which validates high discriminative ability.
Performance Stability Across Validation Folds
Boxplots of AUC, sensitivity, specificity, and accuracy are
used to show the consistency of diagnostic performance
between the validation folds. Figure
The fact that the dispersion is still low in all the measures, especially in the case of AUC and specificity, shows that it is highly robust and does not seem to rely on a particular data partition. This is due to the fact that the relatively greater spread in sensitivity indicates conservative detection behavior of certain folds, which is more clinically desirable than over-reporting false-positives.
Receiver Operating Characteristic Analysis
To further investigate the discriminative behavior of
the proposed framework, receiver operating characteristic
(ROC) curves were also constructed in each of the
validation folds. The curves of receiver operating characteristics
(ROC) that were obtained during 10-fold
cross-validation are shown in Figure
The ROC curves are always near to the upper-left part, which proves the high true-positive values at low false-positive ones and proves the high level of discrimination of the model.
Aggregated Error Analysis and Clinical Safety
The confusion outcomes were summed up in Table
The low percentage of false-positive (1.96) in Table
Statistical Comparison with Baseline Models
The proposed framework was statistically compared to
conventional baseline classifiers in terms of diagnostic
performance using the Wilcoxon signed-rank test of the
AUC values and fold-wise results and a table was provided
in Table
The analysis indicates that there is statistically significant enhancement over the distance-based K-Nearest Neighbors (KNN) classifier (p<0.01) but the performance was statistically the same as the other robust baseline classification models, such as, logistic regression, random forest, support vector machine, and XGBoost.
These results demonstrate strong discriminative performance under cross-validated benchmark conditions, while acknowledging that performance on curated datasets may not directly translate to real-world clinical settings.
Discussion and Clinical Interpretation
The findings show that the hybrid deep-ensemble
model proposed has good and consistent diagnostic
accuracy in the early detection of breast cancer when
subjected to stringent cross-validation. Instead of concentrating
only on marginal improvements in accuracy,
the framework concentrates on the outcome stability,
false-positive suppression, and clinical safety that are
important factors in the application of diagnostic decision
support in real-world settings.
From a clinical perspective, the use of synthetic resampling techniques is primarily intended to support balanced learning rather than to simulate biological heterogeneity. The consistently high specificity and low false-positive rates observed across validation folds suggest that the inclusion of synthetic minority samples did not result in overly aggressive sensitivity or unsafe diagnostic behavior. Instead, the framework exhibits conservative decision characteristics, which are generally preferable in breast cancer screening contexts where false-positive reduction is a critical concern.
The fact that the latent deep representations are combined with the clinically interpretable features is a feature that allows the identification of the nonlinear pattern of diagnosis without the loss of transparency. The ensemble feature selection and stacked classification also lead to less variability of performance in the different validation folds. Notably, the framework can attain these results without using raw imaging data or architectures that require extensive computation, which makes it plausible to implement it in resource-limited clinical settings. While the proposed architecture introduces additional components compared to single-model baselines, this complexity is justified by improved outcome stability and conservative diagnostic behavior rather than by isolated accuracy improvements. The consistently high accuracy and AUC values observed across validation folds should be interpreted with caution. The WDBC dataset is a well-curated and widely used benchmark, and strong performance may partly reflect dataset saturation rather than generalizable real-world diagnostic behavior. Although stratified cross-validation and strict train-test separation were employed to mitigate overfitting, external validation on independent and heterogeneous clinical datasets is necessary to confirm generalizability and clinical robustness.
Despite the encouraging results, this study has several important limitations. First, the evaluation is restricted to the WDBC dataset, which is a curated benchmark dataset derived from fine-needle aspirate-based diagnostic features rather than population-level screening or raw imaging data. Consequently, the findings should be interpreted as proof-of-concept evidence demonstrating diagnostic stability and robustness under controlled validation settings. External validation using multi-institutional datasets, prospective cohorts, and imaging-based screening data is required before the framework can be considered for real-world clinical deployment. Nevertheless, the present results establish a reliable methodological foundation for such future translational studies.
The hybrid deep-ensemble framework that is proposed in this paper shows a good, consistent, and clinically viable performance in detecting breast cancer in its early stages with a high level of discrimination, low false-positive probability, and statistically stable comparative performance, which adds evidence to the translational viability in the use of the framework as a decision-support system in breast cancer diagnosis. Although the proposed framework emphasizes interpretability at the system and feature-integration level, no explicit feature-attribution or explainability analysis of individual latent dimensions was performed, which represents an important direction for future work.
The framework demonstrated consistently high specificity, low false-positive rates, and strong discriminative ability across stratified cross-validation, supporting its potential role as a screening-support tool aimed at minimizing unnecessary follow-up procedures and patient anxiety. Statistical analysis further indicated robust performance relative to commonly used baseline models, reinforcing the reliability of the framework under repeated validation rather than dependence on single-split performance.
From an oncology perspective, the proposed model is computationally efficient and interpretable, making it a promising decision-support prototype for further translational research rather than an immediately deployable clinical screening system. While the demonstrates consistently strong diagnostic performance under benchmark validation, supporting its value as a proof-of-concept decision-support framework, future studies will involve external datasets and prospective clinical evaluation are essential to fully establish realworld screening applicability.
Informed Consent: Informed consent was no need Informed consent.
Conflict of Interest Statement: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. All authors declare no conflict of interest for this article.
Funding: No Funding support is provided for this paper publication.
Use of AI for Writing Assistance: No AI technologies utilized.
Author Contributions: Concept - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Design ? P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Materials - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Data collection and/or processing - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Data analysis and/or interpretation - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Literature search - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Writing - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.; Critical review - P.P., K.U., P.K., G.V.R., S.B.K., A.K., R.J.
Acknowledgments: The authors gratefully acknowledge all individuals and institutions who provided support and resources for the successful completion of this work.
Peer-review: Externally peer-reviewed.
